Novel Coronavirus (SARS-CoV-2/COVID-19)
Long COVID — with symptoms ranging from fatigue and dizziness to shortness of breath and loss of smell — is disabling millions of Americans.
The Centers for Medicare & Medicaid Services yesterday released a fact sheet summarizing the status of public and private coverage for COVID-19 vaccines, testing, and treatments and certain blanket waivers for health care providers once the public health emergency ends on May 11.
The Food and Drug Administration Friday authorized for emergency use the first over-the-counter test to detect both flu and SARS-CoV-2, the virus that causes COVID-19. The Lucira COVID-19 & Flu Home Test provides results from self-collected nasal swab samples in about 30 minutes.
The Drug Enforcement Administration Friday proposed limiting telehealth prescriptions for buprenorphine and other controlled substances after the COVID-19 public health emergency to a 30-day supply unless the prescriber or referring clinician have evaluated the patient in person. DEA will accept…
GE Healthcare expects supplies of its iohexol and iodixanol intraveneous contrast media products for computed tomography imaging to return to normal in the next few weeks.
Centers for Disease Control and Prevention Director Rochelle Walensky, M.D., has restructured the agency to better respond to COVID-19 and other public health threats, Health and Human Services Secretary Xavier Becerra announced.
The Department of Health and Human Services yesterday renewed the COVID-19 public health emergency for 90 days, and told states to expect the PHE and certain flexibilities to end May 11
For three years, hospitals, health systems and health care workers have been on the front lines of the greatest public health crisis our nation has faced in a century.
In a new public service announcement, leaders of the AHA, American Medical Association and American Nurses Association encourage the public to get vaccinated and boosted against COVID-19 when eligible to protect themselves, their families and communities from serious disease and death.
When the omicron BA.4/BA.5 variants were circulating, Americans who received an updated COVID-19 vaccine were 14 times less likely to die than those who received no vaccine and five times less likely to die than those who received the original monovalent vaccine, according a study released today by…